A new trading day began on Friday, with Pulmonx Corp (NASDAQ: LUNG) stock price up 6.25% from the previous day of trading, before settling in for the closing price of $3.20. LUNG’s price has ranged from $2.83 to $9.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 20.78% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -6.92%. With a float of $35.32 million, this company’s outstanding shares have now reached $40.25 million.
In an organization with 291 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 73.58%, operating margin of -66.0%, and the pretax margin is -64.76%.
Pulmonx Corp (LUNG) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Pulmonx Corp is 12.26%, while institutional ownership is 85.88%. The most recent insider transaction that took place on Mar 20 ’25, was worth 157,000. In this transaction Director of this company sold 20,000 shares at a rate of $7.85, taking the stock ownership to the 991,974 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Director proposed sale 60,000 for $7.77, making the entire transaction worth $466,200.
Pulmonx Corp (LUNG) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -6.92% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.76% during the next five years compared to -19.80% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
Here are Pulmonx Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.45, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.39 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Let’s dig in a bit further. During the last 5-days, its volume was 0.42 million. That was better than the volume of 0.35 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 54.55%. Additionally, its Average True Range was 0.34.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 8.72%, which indicates a significant decrease from 61.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.40% in the past 14 days, which was lower than the 89.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.86, while its 200-day Moving Average is $6.44. However, in the short run, Pulmonx Corp’s stock first resistance to watch stands at $3.55. Second resistance stands at $3.71. The third major resistance level sits at $3.93. If the price goes on to break the first support level at $3.18, it is likely to go to the next support level at $2.96. The third support level lies at $2.80 if the price breaches the second support level.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
With a market capitalization of 136.88 million, the company has a total of 40,258K Shares Outstanding. Currently, annual sales are 83,790 K while annual income is -56,390 K. The company’s previous quarter sales were 22,540 K while its latest quarter income was -14,450 K.
